Replies to post #23484 on Mymetics Corp (MYMX)

[bow-tie]

From Last post Lookie!!

Guidance
Influenza vaccine: ovalbumin content
Data on the ovalbumin content of the influenza vaccines for the 2020 to 2021 flu season.

https://www.gov.uk/government/publications/influenza-vaccine-ovalbumin-content

[Work Harder]

Blank group

https://www.dbmr.unibe.ch/research/research_groups/pulmonary_medicine_adults/index_eng.html

Dr. Mario Amacker

[Work Harder]

From your fist link

However, in context of IPF, recent findings regarding involvement of Tregs were controversial in human IPF and BLM animal models alike.

Did they just tell us Friday that they have this worked out w/ Tregs...!!!!!!

[Work Harder]

All that needs a good read

Virosome-bound antigen enhances DC-dependent specific CD4 + T cell stimulation, inducing a Th1 and Treg profile in vitro

https://pubmed.ncbi.nlm.nih.gov/28214610/

[Work Harder]

Acknowledgement

The MIC kindly asks all users of the LCI Core Facility to acknowledge the support of the Microscopy Imaging Centre (MIC) in any publication with data obtained with MIC equipment. A gesture of recognition may be done by simply acknowledging that the study was performed with the support of the Microscopy Imaging Center (MIC), Uni-versity of Bern.

https://www.dbmr.unibe.ch/services/core_facilities/live_cell_imaging/research/index_eng.html

Microscopy Imaging Center

https://www.mic.unibe.ch/

[Work Harder]

Medical Faculty (PDF, 14.79 MB)

Annual Report 2019

Second link from bottom in that

https://www.medizin.unibe.ch/unibe/portal/fak_medizin/content/e505560/e950837/JBMedizin2019_web_ger.pdf

Department for Pulmonary Medicine
Inselspital, 3010 Bern

Profile

Focusing on novel therapeutic treatment modalities including stem cells and their secretome, virosomes/liposomes,
mRNA and targeting novel pathophysiological pathways in obstructive and fibrotic lung diseases

Grants

OPO-Stiftung Zürich and Lungenliga Bern: Efficient Pulmonary Mucosal Allergen Immunotherapy in allergic Airways
Disease Employing Virosomes as Nanocarriers for Antigen and Adjuvant (PD F. Blank)

https://translate.google.com/translate?hl=en&sl=de&u=http://www.opo-stiftung.ch/stiftung/stiftung.html&prev=search&pto=aue

Funding: The study was supported by a research fund of the Swiss Lung Association (Lungenliga Schweiz
2014-13), Switzerland, and OPO Stiftung, Switzerland.

https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjk4p-4oZzvAhVUHc0KHY53DIYQFjACegQIBBAD&url=https%3A%2F%2Fwww.mdpi.com%2F1999-4923%2F12%2F9%2F793%2Fpdf&usg=AOvVaw1xJvPeirzgQxFzP4Fn2ZoS